Editorial: Traditional Medicine and Rheumatology

Front Pharmacol. 2021 Jun 24:12:707811. doi: 10.3389/fphar.2021.707811. eCollection 2021.

Zhihua Yang¹, Xuan Tang¹, Huasheng Liang¹, Kaixin Gao¹, Maojie Wang^{1

2

3

4

5}, Xiaojuan He⁶, Per-Johan Jakobsson⁷, Runyue Huang^{1

2

3

4}

¹ Guangzhou University of Chinese Medicine, Guangzhou, China.
² Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
³ State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
⁴ Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.
⁵ Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
⁶ China Academy of Chinese Medical Sciences, Beijing, China.
⁷ Karolinska Institutet (KI), Solna, Sweden.

No abstract available

Keywords: disease-modifying antirheumatic drug (DMARD); mechanism study; rheumatoid arthritis; rheumatology; traditional Chinese medicine.

Publication types